A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Artivion, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 21,832 shares of AORT stock, worth $617,190. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,832
Previous 19,524 11.82%
Holding current value
$617,190
Previous $500,000 16.2%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$24.33 - $28.46 $56,153 - $65,685
2,308 Added 11.82%
21,832 $581,000
Q2 2024

Aug 14, 2024

BUY
$19.62 - $25.65 $383,060 - $500,790
19,524 New
19,524 $500,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.14B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.